A Win For Viking Therapeutics, Inc.

Mon, Dec 19, 2022 at 07:02 PM
A Win For Viking Therapeutics, Inc.

Viking Therapeutics, Inc. (VKTX:NASDAQ) soared at $6.99, representing a gain of 73.9%. On Mon, Dec 19, 2022, VKTX:NASDAQ touched a New 2-Week High of $6.99. The stock got featured on our News Catalysts scanner on Mon, Dec 19, 2022 at 09:25 AM in the 'MISCELLANEOUS' category. From Mon, Dec 05, 2022, the stock recorded 70.00% Up Days and 45.45% Green Days

About Viking Therapeutics, Inc. (VKTX:NASDAQ)

Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.